Gemini PharmChem Mannheim GmbH

Gemini PharmChem Mannheim GmbH is a part of Synbias-Gemini Group. The Synbias-Gemini Group operates under the umbrella of Synbias Pharma AG, headquartered in Schaffhausen, Switzerland, which 100% shareholder of Gemini PharmChem Mannheim GmbH. Gemini PharmChem Mannheim GmbH is the production facilities, a highly esteemed manufacturing and R&D site located in Mannheim, Germany. As the leading global API supplier of anthracycline antibiotics, we hold a 30-50% share of the world market. Annually, approximately 200 kilograms of our APIs, in quantities ranging from 100 grams to 15 kilograms, are shipped to customers in 21 countries across 5 continents. Our Quality System is...

Drug manufacturing,pharmaceuticals,commercial production,commercial manufcacturing,hpapi manufacturing,nucleosides manufacturing,pharmaceutical process innovation,custom api production,new molecule development,innovative api solutions,anthracyclines production,anthracyclines marke leader,api research and development,contract development and manufacturing organization in cytostatic,contract development manufacturing organization (cdmo) highly potent apis,pharmaceutical partnerships,regulatory compliance apis,doxorubicin hci,epirubicin hci,idarubicin hci,valrubicin,pirarubicin,nelarabine,and cladribine premix

Gemini pharmchem mannheim gmbh operates in the Pharmaceutical manufacturing industry.

Gemini pharmchem mannheim gmbh's revenue is 11m - 100m

Gemini pharmchem mannheim gmbh has 11 - 50 employees.